Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

Diabetes Care

Volumn 20, Issue 4, 1997, Pages 614-620

  Pyörälä, Kalevi ^a   Pedersen, Terje R ^b   Kjekshus, John ^c   Faergeman, Ole ^d   Olsson, Anders G ^e   Thorgeirsson, Gudmundur ^f  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b AKER UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^f LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

SIMVASTATIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SCANDINAVIA;

EID: 1842326783     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.4.614     Document Type: Article

References (23)

1. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham Study. JAMA 241:2035-2038, 1979
2. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Coronary-heart-disease and impaired glucose tolerance: the Whitehall Study. Lancet i:1373-1376, 1980
3. Rosengren A, Welin L, Tsipogianni A, Wilhelmsen L: Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. Br Med J 299:1127-1131, 1989
4. Laakso M, Rönnemaa T, Lehto S, Puukka P, Kallio V, Pyörälä K: Does NIDDM increase the risk for coronary heart disease similarly in both low- and high-risk populations? Diabetologia 38:487-493, 1995
5. Smith JW, Marcus FI, Serokman R, the Multicenter Postinfarction Research Group: Prognosis of patients with diabetes mellitus after myocardial infarction. Am J Cardiol 54:718-721, 1984
6. Ulvenstam G, Åberg Å, Bergstrand R, Bergstrand R, Johansson S, Pennert K, Vedin A, Wilhelmsen L, Wilhelmsson C: Long-term prognosis after myocardial infarction in men with diabetes. Diabetes 34:787-792, 1985
7. Abbot RD, Donahue RP, Kannel WB, Wilson PW: The impact of diabetes on survival following myocardial infarction in men vs. women: the Framingham Study. JAMA 260:3456-3460, 1988
8. Malmberg K, Rydén L: Myocardial infarction in patients with diabetes. Eur Heart J 9:259-264, 1988
9. Herlitz J, Karlson BW, Edvardsson N, Emanuelsson H, Hjalmarson Å: Prognosis in diabetics with chest pain or other symptoms suggestive of acute myocardial infarction. Cardiology 80:237-245, 1992
10. Pyörälä K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 3:463-524, 1987
11. Laakso M: Epidemiology of diabetic dyslipidemia. Diabetes Rev 3:408-422, 1995
12. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors: the Framingham Study. Circulation 59:8-13, 1979
13. Stamler J, Vaccaro O, Neaton JD, Wentworth D, the Multiple Risk Factor Intervention Trial Research Group: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
14. Koskinen P, Mänttäri M, Manninen V. Huttunen JK, Heinonen OP, Frick MH: Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care 15:820-825, 1992
15. The Scandinavian Simvastatin Survival Study Group: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-1389, 1994
16. Kjekshus J, Pedersen TR, the Scandinavian Simvastatin Survival Study group: Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S). Am J Cardiol 76:64C-68C, 1995
17. The Scandinavian Simvastatin Survival Study Group: Design and baseline results of the Scandinavian Simvastatin Survival Study of patients with stable angina and/or previous myocardial infarction. Am J Cardiol 71:393-400, 1993
18. Cox DR: Regression methods of life tables (with discussion). JR Stat Soc B34:187-220, 1972
19. Fontbonne A, Eschwège E, Cambien F, Richard JL, Ducimetière P, Thibult N, Warnet JM, Claude JR, Rosselin GE: Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32:300-304, 1989
20. Laakso M, Lehto S, Penttilä I, Pyörälä K: Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 88:1421-1430, 1993
21. Scandinavian Simvastatin Survival Study Group: Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S). Lancet 345:1274-1275, 1995
22. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW McKillop JH, Packard CJ, the West of Scotland Coronary Prevention Study Group: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333:1301-1307, 1995
23. Miettinen H, Niemelä M, Lehto S, Haffner SM, Salomaa W, Mähönen M, Tuomilehto J, the FINMONICA AMI Register Group: Short and long-term case fatality of myocardial infarction in diabetic and nondiabetic patients (Abstract). Diabetologia 38 (Suppl. 1):A20, 1994